WallStreetZenWallStreetZen

NASDAQ: VSTM
Verastem Inc Stock Forecast, Predictions & Price Target

Analyst price target for VSTM

Based on 4 analysts offering 12 month price targets for Verastem Inc.
Min Forecast
$17.50+77.85%
Avg Forecast
$27.63+180.74%
Max Forecast
$34.00+245.53%

Should I buy or sell VSTM stock?

Based on 4 analysts offering ratings for Verastem Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VSTM stock forecasts and price targets.

VSTM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-19
lockedlocked$00.00+00.00%2024-03-15
lockedlocked$00.00+00.00%2023-11-21
lockedlocked$00.00+00.00%2023-11-15

1 of 1

Forecast return on equity

Is VSTM forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is VSTM forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

VSTM revenue forecast

What is VSTM's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$33.8M
Avg 2 year Forecast
$94.4M
Avg 3 year Forecast
$191.8M

VSTM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VSTM$9.84$27.63+180.74%Strong Buy
HOWL$5.90$13.50+128.81%Buy
XBIT$8.04N/AN/A
FENC$9.34$18.00+92.72%Buy
XERS$1.74$5.00+187.36%Strong Buy

Verastem Stock Forecast FAQ

Is Verastem Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: VSTM) stock is to Strong Buy VSTM stock.

Out of 4 analysts, 2 (50%) are recommending VSTM as a Strong Buy, 2 (50%) are recommending VSTM as a Buy, 0 (0%) are recommending VSTM as a Hold, 0 (0%) are recommending VSTM as a Sell, and 0 (0%) are recommending VSTM as a Strong Sell.

If you're new to stock investing, here's how to buy Verastem stock.

What is VSTM's revenue growth forecast for 2025-2027?

(NASDAQ: VSTM) Verastem's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Verastem's revenue in 2024 is $0.On average, 3 Wall Street analysts forecast VSTM's revenue for 2025 to be $854,557,708, with the lowest VSTM revenue forecast at $252,954,950, and the highest VSTM revenue forecast at $1,923,216,485. On average, 3 Wall Street analysts forecast VSTM's revenue for 2026 to be $2,386,705,840, with the lowest VSTM revenue forecast at $1,687,968,381, and the highest VSTM revenue forecast at $3,650,898,793.

In 2027, VSTM is forecast to generate $4,851,068,849 in revenue, with the lowest revenue forecast at $3,832,520,447 and the highest revenue forecast at $5,792,668,355.

What is VSTM's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VSTM) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is VSTM's Price Target?

According to 4 Wall Street analysts that have issued a 1 year VSTM price target, the average VSTM price target is $27.63, with the highest VSTM stock price forecast at $34.00 and the lowest VSTM stock price forecast at $17.50.

On average, Wall Street analysts predict that Verastem's share price could reach $27.63 by Mar 19, 2025. The average Verastem stock price prediction forecasts a potential upside of 180.74% from the current VSTM share price of $9.84.

What is VSTM's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VSTM) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.